Cis-regulatory elements controlling basal and inducible VIP gene transcription

Annals of the New York Academy of Sciences

Volumn 865, Issue , 1998, Pages 10-26

  Hahm, Sung Ho ^a   Eiden, Lee E ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; PHORBOL ESTER; PROTEIN KINASE; TRANSACTIVATOR PROTEIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; CELL SPECIFICITY; CONFERENCE PAPER; CONTROLLED STUDY; ENHANCER REGION; HUMAN; HUMAN CELL; NONHUMAN; PROMOTER REGION; RAT; REPORTER GENE; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0032418165     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb11158.x     Document Type: Conference Paper

References (49)

1. Eiden, L. E., R. L. Eskay, J. Scott, H. Pollard & A. J. Hotchkiss. 1983. Primary cultures ofbovine chromaffin cells synthesize and secrete vasoactive intestinal polypeptide (VIP). LifeSci. 33: 687-693.
2. MacArthur, L. & L. E. Eiden. 1996. Neuropeptide genes: targets of activity-dependent signaltransduction. Peptides 17: 721-728.
3. Eiden, L. E., P. Giraud, J. Dave, J. A. Hotchkiss & H.-U. Affolter. 1984. Nicotinic receptorstimulation activates both enkephalin release and biosynthesis in adrenal chromaffin cells.Nature 312: 661-663.
4. Waschek, J. A., R. M. Pruss, R. E. Siegel, L. E. Eiden, M.-F. Bader & D. Aunis. 1987.Regulation of enkephalin, VIP and chromogranin A biosynthesis in actively secreting chromaffin cells: multiple strategies for multiple peptides. Ann. N.Y. Acad. Sci. 493: 308-323.
5. Tatsuno, I., T. Yada, S. Vigh, H. Hidaka & A. Arimura. 1992. Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) increase cytosolic freecalcium concentration in cultured rat hippocampal neurons. Endocrinology 133: 73-81.
6. 2+channel currents in vascular smooth muscle cells: involvement of PKC and PKA. FASEB J.10: 1310-1317.
7. Miyata, A., A. Arimura, R. R. Dahl, N. Minamino, A. Uehara, L. Jiang, M. D. Culler & D.H. Coy. 1989. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulatesadenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164: 567-574.
8. Eiden, L. E., P. Giraud, H.-U. Affolter, E. Herbert & A. J. Hotchkiss. 1984. Alternate modesof enkephalin biosynthesis regulation by reserpine and cyclic AMP in cultured chromaffincells. Proc. Natl. Acad. Sci. USA 81: 3949-3953.
9. Eskay, R. L. & L. E. Eiden. 1992. Interleukin-1 alpha and tumor necrosis factor alpha differentially regulate enkephalin, vasoactive intestinal polypeptide, neurotensin, and substance Pbiosynthesis in chromaffin cells. Endocrinology 130: 2252-2258.
10. Darnell Jr., J. E. 1997. STATs and gene regulation. Science 277: 1630-1634.
11. Symes, A. J., M. S. Rao, S. E. Lewis, S. C. Landis, S. E. Hyman & J. S. Fink. 1993. Ciliaryneurotrophic factor coordinately activates transcription of neuropeptide genes in a neuroblastoma cell line. Proc. Natl. Acad. Sci. USA 90: 572-576.
12. Symes, A., T. Gearan, J. Eby & J. S. Fink. 1997. Integration of Jak-Stat and AP-1 signalingpathways at the vasoactive intestinal peptide cytokine response element regulates ciliary neurotrophic factor-dependent transcription. J. Biol. Chem. 272: 9648-9654.
13. Symes, A., S. Lewis, L. Corpus, P. Rajan, S. E. Hyman & J. S. Fink. 1994. STAT proteins participate in the regulation of the vasoactive intestinal peptide gene by the ciliary neurotrophicfactor family of cytokines. Mol. Endocrinol. 8: 1750-1763.
14. Symes, A. J., P. Rajan, L. Corpus & J. S. Fink. 1995. C/EBP-related sites in addition to a Statsite are necessary for ciliary neurotrophic factor-leukemia inhibitory factor-dependent transcriptional activation by the vasoactive intestinal peptide cytokine response element. J. Biol.Chem. 270: 8068-8075.
15. Segal, R. A. & M. E. Greenberg. 1996. Intracellular signaling pathways activated by neurotrophic factors. Ann. Rev. Neurosci. 19: 463-489.
16. Xing, J., D. D. Ginty & M. E. Greenberg. 1996. Coupling of the RAS-MAPK pathway to geneactivation by RSK2, a growth-factor-regulated CREB kinase. Science 273: 959-963.
17. 2+ and stimulus duration-dependent switch for hippocampal gene expression. Cell 87:1203-1214.
18. Foster, G. A., L. E. Eiden & D. E. Brenneman. 1989. Regulation of discrete sub-populationsof transmitter-identified neurons after inhibition of electrical activity in cultures of mousespinal cord. Cell Tissue Res. 256: 543-552.
19. Agoston, D. V., L. E. Eiden, D. E. Brenneman & I. Gozes. 1991. Spontaneous electrical activity regulates vasoactive intestinal peptide expression in dissociated spinal cord cell cultures.Mol. Brain Res. 10: 235-240.
20. Tsukada, T., S. J. Horovitch, M. R. Montminy, G. Mandel & R. H. Goodman. 1985. Structureof the human vasoactive intestinal polypeptide gene. DNA 4: 293-300.
21. Tsukada, T., J. S. Fink, G. Mandel & R. H. Goodman. 1987. Identification of a region in thehuman vasoactive intestinal polypeptide gene responsible for regulation by cyclic AMP. J.Biol. Chem. 262: 8743-8747.
22. Waschek, J. A., C.-M. Hsu & L. E. Eiden. 1988. Lineage-specific regulation of the vasoactiveintestinal peptide gene in neuroblastoma cells is conferred by 5.2 kilobases of 5′-flankingsequence. Proc. Natl. Acad. Sci. USA 85: 9547-9551.
23. Hahm, S. H. & L. E. Eiden. 1996. Tissue-specific expression of the vasoactive intestinal peptidegene requires both an upstream tissue specifier element and the 5′ proximal cAMP-responsive element. J. Neurochem. 67: 1872-1881.
24. Yamagami, T., K. Ohsawa, M. Nishizawa, C. Inque, E. Gotoh, N. Yanaihara, H. Yamamoto& H. Okamoto. 1988. Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter. Ann. N. Y. Acad. Sci. 527: 87-102.
25. Sena, M., D. T. Bravo, D. V. Agoston & J. A. Waschek. 1994. High conservation of upstreamregulatory sequences on the human and mouse vasoactive intestinal peptide (VIP) genes. DNASeq. 5: 25-29.
26. Hahm, S. H. & L. E. Eiden. 1998. Five discrete cis-active domains direct cell type-specific transcription of the vasoactive intestinal peptide (VIP) gene. J. Biol. Chem. 273: 17083-17094.
27. Herr, W., R. A. Sturm, R. G. Clerc, L. M. Corcoran, D. Baltiore, P. A. Sharp, H. A.Ingraham, M. G. Rosenfeld, M. Finney, G. Ruvkun & H. R. Horvitz. 1988. The POUdomain: A large conserved region in the mammalian Pit-1, Oct-1,Oct-2 and Caenorrhabditiselegans Unc-86 gene products. Genes & Dev. 2: 1513-1516.
28. Herr, W. & M. A. Clearly. 1995. The POU domain: versatility in transcriptional regulation bya flexible two-in-one DNA-binding domain. Genes & Dev. 9: 1679-1693.
29. Clark, M. E. & P. L. Mellon. 1995. The POU homeodomain transcription factor Oct-1 isessential for activity of the gonadotropin-releasing hormone neuron-specific enhancer. Mol.Cell Biol. 15: 6169-6177.
30. Guillemot, F., L.-C. Lo, J. E. Hohnson, A. Auerbach, D. J. Anderson & A. L. Joyner. 1993.Mammalian achaete-scute homolog 1 is required for the early development of olfactory andautonomic neurons. Cell 75: 463-476.
31. Guillemot, F. 1995. Analysis of the role of basic-helix-loop-helix transcription factors in thedevelopment of neural lineages in the mouse. Biol. Cell 84: 3-6.
32. Black, B. L., K. L. Ligon, Y. Zhang & E. N. Olson. 1997. Cooperative transcriptional activation by the neurogenic basic helix-loop-helix protein MASH1 and members of the myocyteenhancer factor-2 (MEF2) family. J. Biol. Chem. 271: 26659-26663.
33. Leifer, D., Y.-L, Li & K. Wehr. 1997. Myocyte-specific enhancer binding factor 2C expressionin fetal mouse brain development. J. Mol. Neurosci. 8: 131-143.
34. Kishimoto, T., S. Akira & T. Taga. 1992. Interleukin-6 and its receptor: A paradigm forcytokines. Science 258: 593-597.
35. Ihle, J. N. 1996. STATs: Signal transducers and activators of transcription. Cell 84: 331-334.
36. Wasylyk, B., C. Wasylyk, P. Flores, A. Begue, D. Leprince & D. Stehelin. 1990. The c-etsproto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature 346: 191-193.
37. Leonard, J., P. Serup, G. Gonzalez, T. Edlund & M. Montminy. 1992. The LIM family transcription factor Isl-1 requires cAMP response element binding protein to promote somatostatinexpression in pancreatic islet cells. Proc. Natl. Acad. Sci. USA 89: 6247-6251.
38. Agoston, D. V., D. T. Bravo & J. A. Waschek. 1990. Expression of a chimeric VIP gene is targeted to the intestine in transgenic mice. J. Neurosci. Res. 27: 479-486.
39. Tolentino, P. J., P. Dikkes, L. Tsuruda, K. Ebert, J. S. Fink, L. Villa-Komaroff & E. D. Lamperti. 1995. Quantitative analysis of the expression of a VIP transgene. Mol. Brain Res.33: 47-60.
40. Tsuruda, L. M., E. D. Lamperti, S. E. Lewis, P. J. Tolentino, P. Dikkes, L. Villa-Komaroff, K.M. Ebert & J. S. Fink. 1996. Region-specific central nervous system expression and axotomy-induced regulation in sympathetic neurons of a VIP-β-galactosidase fusion gene in transgenicmice. Mol. Brain Res. 42: 181-192.
41. Zwilling, S., A. Dieckmann, P. Pfisterer, P. Angel & T. Wirth. 1997. Inducible expressionand phosphorylation of coactivator BOB.1/OBF.1 inT cells. Science 277: 221-226.
42. Chong, J. A., J. Tapia-Ramirez, S. Kim, J. J. Toledo-Arai, Y. Zheng, M. C. Boutros, Y. M.Altshuller, M. A. Frohman, S. D. Kraner & G. Mandel. 1995. REST: a mammaliansilencer protein that restricts sodium channel gene expression to neurons. Cell 80: 949-957.
43. Schoenherr, C. J. & D. J. Anderson. 1995. The neuron-restrictive silencer factor (NRSF): acoordinate repressor of multiple neuron-specific genes. Science 267: 1360-1363.
44. Schoenherr, C. J., A. J. Paquette & D. J. Anderson. 1997. Identification of potential targetgenes for the neuron-restrictive silencer element. Proc. Natl. Acad. Sci. USA 93: 9881-9886.
45. Erickson, J. D., E. Weihe, M.K.-H. Schäfer, E. Neale, L. Williamson, T. I. Bonner, J.-H.Tao-Cheng & L. E. Eiden. The VAChT/ChAT "cholinergic gene locus": new aspects ofgenetic and vesicular regulation of cholinergic function. In Cholinergic Mechanisms: FromMolecular Biology to Clinical Significance. J. Klein & K. Löffelholz, Eds. 69-82. Elsevier.Amsterdam.
46. Lönnerberg, P., C. J. Schoenherr, D. J. Anderson & C. F. Ibanez. 1996. Cell type-specificregulation of choline acetyltransferase gene expression. Role of the neuron-restrictive silencerelement and cholinergic-specific enhancer sequences. J. Biol. Chem. 271: 33358-33365.
47. Hahm, S. H., L. Chen, C. Patel, J. Erickson, T. I. Bonner, E. Weihe, M.K.-H. Schäfer & L.E. Eiden. 1997. The human cholinergic gene locus: Upstream sequencing, in vivo transcription patterns, and role of the NRSE/RE-1 and other control elements in VAChT expression. J.Mol. Neurosci. 9: 223-236.
48. Eiden, L. E. & A. J. Hotchkiss. 1983. Cyclic adenosine monophosphate regulates vasoactiveintestinal polypeptide and enkephalin biosynthesis in cultured bovine chromaffin cells.Neuropeptides 4: 1-9.
49. Rausch, D. M., A. L. Iacangelo & L. E. Eiden. 1988. Glucocorticoid- and nerve growth factor-induced changes in chromogranin A expression define two different neuronal phenotypesin PC12 cells. Mol. Endocrinol. 2: 921-927.